Recent studies have demonstrated the importance of this, showing that a combination of CD44v6 and CD44s, but not CD44 alone, is able to predict survival in lung cancer patients (47), while pancreatic tumors with a “CD44v6+/CD44−” profile are more metastatic (41). Here, CD44 is linked to lung cancer.